PRO and Wearable Data Insights From Individuals With R/?R Multiple Myeloma

Complete Title: Evaluating Patient-Reported Outcomes and Wearable Data among Individuals with Relapsed/Refractory Multiple Myeloma
Trial Phase: N/A
Investigator: Rahul Banerjee

This study will evaluate the feasibility of a digital health coaching program for adults with relapsed or refractory multiple myeloma (R/R MM). One hundred adults with R/R MM will be enrolled at The University of Washington. Individuals who agree to take part in the study and sign an informed consent will be enrolled in a 3-month digital health coaching program. The program will provide weekly phone calls plus the delivery of learning materials to text or email. Questionnaires and data from a wrist-worn activity tracker will be collected. Outcomes include treatment and symptom experience, quality of life, financial burden, and how confident people feel to manage their health. Information about your condition and treatment will be collected, along with how often you use services like the emergency room, for care. This data will provide a better understanding of how a person experiences their R/R MM

Keywords:
  • Hematologic Malignancies
  • Multiple Myeloma (MM)
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Checklist icon

Join a Clinical Trial

Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.

Contact Us

If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.

Adult
N/A
Rahul Banerjee
RG1122813
NCT05956457
Evaluating Patient-Reported Outcomes and Wearable Data among Individuals with Relapsed/Refractory Multiple Myeloma
Hematologic Malignancies
Multiple Myeloma (MM)